U.S. Markets close in 2 hrs 36 mins

Aptevo Therapeutics Inc. (APVO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.58+0.07 (+1.08%)
As of 10:04AM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 6.70
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 343.21
52 Week Low 36.23
50-Day Moving Average 38.85
200-Day Moving Average 317.62

Share Statistics

Avg Vol (3 month) 33.56M
Avg Vol (10 day) 398.07k
Shares Outstanding 54.9M
Implied Shares Outstanding 6N/A
Float 84.41M
% Held by Insiders 15.29%
% Held by Institutions 121.07%
Shares Short (Dec 14, 2021) 4309.42k
Short Ratio (Dec 14, 2021) 40.03
Short % of Float (Dec 14, 2021) 410.75%
Short % of Shares Outstanding (Dec 14, 2021) 46.32%
Shares Short (prior month Nov 14, 2021) 487.33k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 26, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3Mar 26, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021


Profit Margin -265.80%
Operating Margin (ttm)-219.81%

Management Effectiveness

Return on Assets (ttm)-29.80%
Return on Equity (ttm)-631.60%

Income Statement

Revenue (ttm)11M
Revenue Per Share (ttm)2.48
Quarterly Revenue Growth (yoy)111.60%
Gross Profit (ttm)-13.54M
EBITDA -23.05M
Net Income Avi to Common (ttm)-29.98M
Diluted EPS (ttm)-6.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.12M
Total Cash Per Share (mrq)10.64
Total Debt (mrq)19.38M
Total Debt/Equity (mrq)265.78
Current Ratio (mrq)1.82
Book Value Per Share (mrq)1.49

Cash Flow Statement

Operating Cash Flow (ttm)-23.92M
Levered Free Cash Flow (ttm)-2.32M